BRCA2 and cancer: This result indicates that having three or more relatives with cancer was a consistent predictor of PV/LPV carriers in FH(+) patients in our cohort, especially for BRCA2. Similar results were observed when the number of relatives with HBOC core cancer was used as a predictor (Supplementary Table S6).